Elevated fibrinogen level, lipoprotein (a), coagulation factors V, VIII, and IX, membrane procoagulant lipid, Plasminogen Activator Inhibitor-1 (PAI-1), homocysteine; thrombocytosis, and platelet dysfunction have been described during IBD. This evidence concerns the gene SERPINE1 and Thrombocytosis.